Sylvain Baruchel

Biography

Dr Baruchel has been a leader in clinical trials in oncology at SickKids as the director of the clinical trial program for 20 years as the founder   the “New Agent and Innovative Therapy Program”   Dr. Baruchel is nationally and internationally recognized for his work in oncology  drug  development. He is  the founder and  former  chair  the  Canadian C17 developmental therapeutic network and current chair of the National Cancer Institute of Canada Paediatric Investigational New Drug committee. He is current  a  senior medical advisor for innovative therapies and his current role is to advise the deparment of pediatric’s   chair and  chair of the research institute on Matters related to innovative therapeutics.  Dr Baruchel collaborates with Dr. Rulan Parekh, the Associate Chair of Clinical Research in leading and developing the infrastructure and processes needed to implement and  conduct SickKids sponsored  innovative therapeutic trials using  novel agents, or devices throughout SickKids.  He is  leading a working group within the Clinical Research Secretariat, an advisory group on clinical research, to develop a pipeline for clinical trials and acts as a resource for the hospital and research institute Principal Investigators looking at early phase trial development.   Dr Baruchel is also a pediatric expert consultant for Canadian Agency for Drugs and Technologies in Health (CADTH). CADTH  is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Research Interest

Translational medicine